Survival outcomes Before PSM, the median OS (mOS) of patients in the RFA group (41 months; 95% confidence interval (CI), 38.6–43.4) was slightly longer than that of patients in the PEI group (34 months; 95% CI, 28.5–39.5), but the difference did not reach statistical significance ( Figure 2 ).
← all excerpts
Efficacy of percutaneous ethanol injection versus radiofrequency ablation for single hepatocellular carcinoma no larger than 5 cm.
1
—
—